Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |